Four former executives of the bankrupt Constellation Healthcare Technologies Inc. have been indicted for bilking investors out of $300 million in connection with a merger designed to take their publicly traded company private, New Jersey federal prosecutors said Thursday.
Medical technology platform Wuxi Apptec Co. Ltd. said Thursday it raised more than $1 billion in an initial public offering on the Hong Kong Stock Exchange, marking the latest Chinese company to access Hong Kong’s international markets through a massive IPO in 2018.
A putative class of auto insurance customers and a putative class of health care providers are jointly suing Allstate over allegedly failing to properly reimburse health costs over car accidents that happened in Pennsylvania but occasioned treatment outside Pennsylvania, according to a suit removed to New Jersey federal court Wednesday.
Molecular manufacturing technology company Zymergen said on Thursday that it has raised over $400 million in its latest round of funding that it will use to accelerate product development and commercialization.
President Donald Trump's cabinet and federal courts from red states chipped away at two key Obama-era benefit policies this year, authorizing the expansion of Affordable Care Act-eschewing health care plans and torpedoing a 2016 regulation intended to protect retirees from self-interested investment advisers.
The U.S. Food and Drug Administration on Thursday said that it was withdrawing a proposed rule that would have allowed generic-drug makers to independently update drug labeling to include new safety information, saying it could have increased industry costs that might have been shifted to patients.
A since-slashed $289 million jury verdict in the first case to go to trial over claims that Monsanto's Roundup weedkiller causes cancer and a mix of verdicts in Johnson & Johnson topped the list of significant product liability cases of 2018.
The independent fiduciary for a failed health benefits plan accused Locke Lord LLP in a complaint filed in Illinois federal court of providing faulty legal advice that ultimately helped to spell the plan’s doom.
A potential class of Amtrak, Lowe’s Companies Inc. and Warner Media LLC employees with HIV and AIDS aren't being discriminated against just because their health plan will only cover medications from CVS Health Corp., a California federal judge ruled in dismissing the workers' suit against the companies.
A manager’s retaliation claim against the Lehigh Valley Health Network Inc. was revived by the Superior Court of Pennsylvania Wednesday when an appellate panel ruled she could bring a claim under the state’s whistleblower law without first going through the Pennsylvania Human Relations Act.
Fentanyl maker Insys Therapeutics Inc. has filed a blistering request in Arizona federal court to wrest documents from Blue Cross Blue Shield over the insurer's allegations that Insys conjured up $19 million worth of bogus prescriptions for the powerful opiate, calling the insurer's attorney-client privilege claims a fiction.
A jury found five of six former New England Compounding Center employees guilty Thursday after a week of deliberations in Boston federal court in the third criminal trial related to the Framingham, Massachusetts, facility, whose contaminated steroids killed 64 and infected almost 800 others in a nationwide meningitis outbreak in 2012.
Blue Cross Blue Shield insurers must face the per se legal standard that if proven says their behavior in allegedly divvying up geographic markets broke the law regardless of the impact on competition, the Eleventh Circuit said Wednesday.
The Eighth Circuit on Wednesday summarily shot down a New York pharmacy’s bid to revive its breach of contract and antitrust suit against Express Scripts Holding Co.
A California appeals court said Tuesday that a “hopelessly” unclear verdict form invalidates a $1.75 million medical malpractice verdict against a hospital whose treatment of a patient with temporarily impaired swallowing power allegedly led to her death.
A Florida appeals court on Wednesday dismissed the appeal of a trial court order ending an attorney’s claims against his former client, a Miami-area chiropractor, whom the attorney claims settled on his own with an insurer to circumvent the lawyer’s right to fees.
The U.S. Food and Drug Administration’s leader on Wednesday said that tougher enforcement is coming in early 2019 for bogus claims or shoddy manufacturing involving stem cell therapies, dietary supplements and compounded drugs.
A New York appellate panel on Wednesday vacated a jury’s decision to clear an anesthesiologist of causing a patient’s death by failing to clear a blocked breathing tube in a timely manner, saying the jury was given improper instructions regarding the “emergency doctrine.”
Nonprofit insurer EmblemHealth has agreed to cover gender reassignment surgery and reimburse policyholders who paid for surgery out of pocket after being denied coverage, the New York attorney general’s office announced Wednesday.
Golden State health care workers don't have to take a second meal break during shifts lasting longer than 12 hours, meaning they can opt to leave work a half hour sooner, the California Supreme Court said Monday.
A federal judge in South Carolina recently sentenced a former speech therapist to 111 months in federal prison on convictions of criminal health care fraud. Practitioners should be aware of the implications as the sentence is an unrequested and unexpected upward departure, say Bart Daniel and Elle Klein of Nelson Mullins Riley & Scarborough LLP.
Many law firms have tickets or luxury suites at sporting events to host clients and prospects. Matthew Prinn of RFP Advisory Group and Matt Ansis of TicketManager discuss some of the ways that firms can use those tickets effectively.
A recent opinion from the American Bar Association provides useful guidance on attorneys’ obligations to guard against cyberattacks, protect electronic client information and respond if an attack occurs, says Joshua Bevitz of Newmeyer & Dillion LLP.
Opening comments by parties in mediation that are made with the proper content and tone can diffuse pent-up emotion and pave the way for a successful resolution. But an opening presentation can do more harm than good if delivered the wrong way, say Jann Johnson and William Haddad of ADR Systems LLC.
In this Lexis Practice Advisor excerpt, Elizabeth Harlan of Astrachan Gunst Thomas offers practical employer strategies for inhibiting and reacting to violence in the workplace.
In the second installment of this three-part legislative preview, Rich Ehisen of State Net Capitol Journal examines a number of issues that should keep state lawmakers occupied next year.
The U.S. Supreme Court recently agreed to hear Cochise Consultancy v. United States ex rel. Hunt, which deepened the circuit split over how the False Claims Act’s statute of limitations applies in certain qui tam actions. The decision should bring sorely needed clarity, say Matthew Curley and Scott Gallisdorfer of Bass Berry & Sims PLC.
With circuit courts irreconcilably split on expert testimony at the class certification stage, the Ninth Circuit’s recent decision not to reconsider Sali v. Corona Regional Medical Center all but guarantees the issue will soon reach the U.S. Supreme Court, say Thomas Richie and John Goodman of Bradley Arant Boult Cummings LLP.
For health care employers, the enactment of Pennsylvania's Medical Marijuana Act has further complicated navigation of reasonable accommodations under the Americans with Disabilities Act. Mariah Passarelli of Cozen O’Connor discusses the pitfalls companies face at the crossroads of these two statutes.
Last week, the Office of Foreign Assets Control took the significant step of adding two digital currency addresses to its list of identifiers for certain individuals related to an Iranian hacking enterprise. This should immediately alert entities that transact in digital assets, says Maxwell T.S. Thompson of Murphy & McGonigle PC.